NOREPINEPHRINE-INDUCED CARDIAC-HYPERTROPHY OF THE CAT HEART

被引:15
|
作者
MARINO, TA [1 ]
CASSIDY, M [1 ]
MARINO, DR [1 ]
CARSON, NL [1 ]
HOUSER, S [1 ]
机构
[1] TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PHYSIOL,PHILADELPHIA,PA 19140
来源
ANATOMICAL RECORD | 1991年 / 229卷 / 04期
关键词
D O I
10.1002/ar.1092290411
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Norepinephrine administration causes progressive hypertrophy of the mammalian heart as measured by myocardial mass. The purpose of this study was to determine the growth response of the myocardial tissue components as well as the myocardial cell itself to norepinephrine. Young, adult cats were given low doses of norepinephrine in dextrose or dextrose alone twice daily for 15 days. On day 16, there were no changes in the animals body weight, right ventricular systolic pressure, right ventricular end-diastolic pressure, heart rate, cardiac index, or blood pressure. However, the right ventricle/body weight, the left ventricle/body weight and the total heart weight/body weight were increased significantly in the norepinephrine treated animals. The increase was on the order of 40%. The cardiac muscle cell was also significantly increased in size and both the right and left ventricular cardiac muscle cells exhibited a dramatic increase in size as measured by cross sectional area. Upon stereological examination it was found that the amount of hypertrophy as seen in the cardiac muscle cells was paralleled by the hypertrophy seen in the other tissue components of the myocardium. The volume density of the muscle cells, the interstitial components, as well as the blood vessel compartment were identical in the control and in the norepinephrine-treated groups. In conclusion, this study demonstrates that the response of the myocardium to norepinephrine is similar to that seen in response to a volume overload rather than that seen in response to pressure overload.
引用
收藏
页码:505 / 510
页数:6
相关论文
共 50 条
  • [1] The effect of Diazoxide on norepinephrine-induced cardiac hypertrophy, in vitro
    Guven, Celal
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (10) : 50 - 54
  • [2] CARDIAC RESPONSES AFTER NOREPINEPHRINE-INDUCED VENTRICULAR HYPERTROPHY IN RATS
    BROWN, L
    SERNIA, C
    NEWLING, R
    FLETCHER, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (02) : 316 - 323
  • [3] Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy
    Singal, T
    Dhalla, NS
    Tappia, PS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (03) : 1015 - 1019
  • [4] NOREPINEPHRINE METABOLISM IN CARDIAC-HYPERTROPHY INDUCED BY THYROID-HORMONE
    ATKINS, F
    LASH, R
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 421 - 421
  • [5] NOREPINEPHRINE-INDUCED HYPERTROPHY OF CULTURED MYOCYTES
    YAMORI, Y
    IGAWA, T
    NARA, Y
    KIHARA, M
    HORIE, R
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1985, 49 (04): : 462 - 462
  • [6] Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation
    Wilfried Briest
    Beate Raßler
    Alexander Deten
    Heinz-Gerd Zimmer
    Molecular and Cellular Biochemistry, 2003, 252 : 229 - 237
  • [7] Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh
    Choi, Eui-Young
    Chang, Woochul
    Lim, Soyeon
    Song, Byeong-Wook
    Cha, Min-Ji
    Kim, Hye-Jung
    Choi, Eunju
    Jang, Yangsoo
    Chung, Namsik
    Hwang, Ki-Chul
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 56 - 62
  • [8] Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation
    Briest, W
    Rassler, B
    Deten, A
    Zimmer, HG
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 252 (1-2) : 229 - 237
  • [9] Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats
    Xiao, DaLiao
    Dasgupta, Chiranjib
    Chen, Man
    Zhang, Kangling
    Buchholz, John
    Xu, Zhice
    Zhang, Lubo
    CARDIOVASCULAR RESEARCH, 2014, 101 (03) : 373 - 382
  • [10] Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation
    Briest, W
    Rassler, B
    Deten, A
    Zimmer, HG
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (06) : A81 - A81